1. Home
  2. VATE vs RFL Comparison

VATE vs RFL Comparison

Compare VATE & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

HOLD

Current Price

$3.90

Market Cap

74.0M

Sector

Industrials

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.27

Market Cap

61.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VATE
RFL
Founded
1994
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Real Estate
Sector
Industrials
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
74.0M
61.1M
IPO Year
1996
2017

Fundamental Metrics

Financial Performance
Metric
VATE
RFL
Price
$3.90
$1.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.2K
101.8K
Earning Date
05-05-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.28
EPS
N/A
N/A
Revenue
$1,107,100,000.00
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$3.91
$1.12
52 Week High
$9.01
$3.19

Technical Indicators

Market Signals
Indicator
VATE
RFL
Relative Strength Index (RSI) 29.21 42.06
Support Level N/A $1.15
Resistance Level $5.37 $1.38
Average True Range (ATR) 0.28 0.13
MACD -0.08 -0.02
Stochastic Oscillator 8.30 0.00

Price Performance

Historical Comparison
VATE
RFL

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: